Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

16.7%

2 terminated out of 12 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

71% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (7)

Trial Status

Completed5
Recruiting2
Terminated2
Not Yet Recruiting1
Active Not Recruiting1
Unknown1

Trial Success Rate

71.4%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (12)

Research Network

Activity Timeline